Search - tctmd.com

Displaying 621 - 640 of 1067

Sort: Relevancy | Date

News Features

The Bioresorbable Stent Story So Far: What Promise? What Price?

Michael O'Riordan

August 17, 2016

News Daily News

Intracoronary Abciximab Shows Advantage in Diabetic STEMI Patients

L.A. McKeown

August 11, 2016

News Daily News

‘Reassuring’ 18-Month Results Seen With Absorb BVS, but Longer-Term Follow-up Still Needed

Michael O'Riordan

August 01, 2016

Presentation

Prolonged High-Dose Bivalirudin Infusion Reduces Major Bleeding Without Increasing Stent Thrombosis in Patients Undergoing Primary PCI

Presenter: Gregor Fahrni

July 27, 2016

News Daily News

Another Meta-Analysis Supports Prolonged Bivalirudin Use in STEMI, but Is Contemporary PCI Reflected?

Yael L. Maxwell

July 27, 2016

News Daily News

Antiplatelet Therapy in Stented Patients Needing Surgery: Italian Experience Provides Direction

Michael O'Riordan

July 20, 2016

News Daily News

Timing and Type of Events Post-PCI Have Implications for Prognosis—and Honest Discussions With Patients

Yael L. Maxwell

July 05, 2016

News Daily News

Now You See It: FDA Approves Absorb Bioresorbable Scaffold

Michael O'Riordan

July 05, 2016

News Daily News

TCTMD’s Top 10 Most Popular Stories for June 2016

Shelley Wood

July 01, 2016

News Daily News

CABG Shows Survival Advantage Over PCI in Nondiabetic Patients With Multivessel Disease

L.A. McKeown

June 29, 2016

News Daily News

Prolonged Full-Dose Bivalirudin May Preserve Bleeding Benefit Without Upping Thrombotic Events After STEMI, Meta-Analysis Suggests

Yael L. Maxwell

June 20, 2016

Presentation

Effect of Post-PPCI Bivalirudin Infusion on Acute Stent Thrombosis: Meta-analysis of RCTs

Presenter: Rahman Shah

June 20, 2016

Presentation TVT 2016

An Update on Subclinical Bioprosthetic Leaflet Thickening and Thrombosis: Possible Effects on TAVR Durability

Presenter: Raj Makkar

June 17, 2016

Presentation TVT 2016

The Incidence, Diagnosis, Impact, and Treatment of Valve Thrombosis After TAVR

Presenter: Azeem Latib

June 17, 2016

Presentation CCVVC 2016

Timing of DAPT Interruption and DES Thrombosis

Presenter: Usman Baber

June 16, 2016

Presentation CCVVC 2016

Subclinical Leaflet Thrombosis Post-TAVR

Presenter: Gian Paolo Ussia

June 16, 2016

Presentation TVT 2016

TVT 1127: Persistent Transcathter Valve Thrombosis Despite Full Anticoagulation

Presenter: Leo Marcoff, MD

June 16, 2016

Presentation TVT 2016

The Natural History of Leaflet Thrombosis and Abnormal Motion in Aortic Bioprosthetic Valves

Presenter: Lars Sondergaard

June 16, 2016

News Daily News

A Tight Spot: Drug-Eluting Stents Seem to Top Other Options for Small-Vessel Disease

Todd Neale

June 16, 2016

News Daily News

Survey of Interventional Cardiologists With Absorb BVS Expertise Gives Snapshot of Attitudes, Usage

Michael O'Riordan

June 14, 2016

Advertisement

The Bioresorbable Stent Story So Far: What Promise? What Price?

Intracoronary Abciximab Shows Advantage in Diabetic STEMI Patients

‘Reassuring’ 18-Month Results Seen With Absorb BVS, but Longer-Term Follow-up Still Needed

Prolonged High-Dose Bivalirudin Infusion Reduces Major Bleeding Without Increasing Stent Thrombosis in Patients Undergoing Primary PCI

Another Meta-Analysis Supports Prolonged Bivalirudin Use in STEMI, but Is Contemporary PCI Reflected?

Antiplatelet Therapy in Stented Patients Needing Surgery: Italian Experience Provides Direction

Timing and Type of Events Post-PCI Have Implications for Prognosis—and Honest Discussions With Patients

Now You See It: FDA Approves Absorb Bioresorbable Scaffold

TCTMD’s Top 10 Most Popular Stories for June 2016

CABG Shows Survival Advantage Over PCI in Nondiabetic Patients With Multivessel Disease

Prolonged Full-Dose Bivalirudin May Preserve Bleeding Benefit Without Upping Thrombotic Events After STEMI, Meta-Analysis Suggests

Effect of Post-PPCI Bivalirudin Infusion on Acute Stent Thrombosis: Meta-analysis of RCTs

An Update on Subclinical Bioprosthetic Leaflet Thickening and Thrombosis: Possible Effects on TAVR Durability

The Incidence, Diagnosis, Impact, and Treatment of Valve Thrombosis After TAVR

Timing of DAPT Interruption and DES Thrombosis

Subclinical Leaflet Thrombosis Post-TAVR

TVT 1127: Persistent Transcathter Valve Thrombosis Despite Full Anticoagulation

The Natural History of Leaflet Thrombosis and Abnormal Motion in Aortic Bioprosthetic Valves

A Tight Spot: Drug-Eluting Stents Seem to Top Other Options for Small-Vessel Disease

Survey of Interventional Cardiologists With Absorb BVS Expertise Gives Snapshot of Attitudes, Usage

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content